GlassScriptPhysician profile
Amit J Shah
NPI 1134246770
$1,498.13
in general payments reported to CMS, 2019-2025
7 companies · $698 in 2025
The $698 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $183 · 2024: $617 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,153 · Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,153.33 |
| Food and Beverage | $344.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $670.00 | 2025 | |
| Zoll Medical Corporation | $483.33 | 2024 | Defibrillator |
| Abbott Laboratories | $258.33 | 2023-2024 | Aveir, Gallant |
| Biocryst US Sales Co., LLC | $43.33 | 2023 | Orladeyo |
| Astrazeneca Pharmaceuticals LP | $14.92 | 2025 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.71 | 2023 | Ofev |
| Electromed, INC. | $13.51 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.